The end of the Phase One Brexit talks should be welcomed as it offers business some clarity in important areas such as citizens' rights. We now move into the next Phase to discuss the complex matter of future UK-EU trading relations and transitions. So what milestones should businesses look out for and what detail can we expect in the coming months?
We have now reached a critical point in the negotiations where leaders need to make decisions and act on their Brexit strategies. The outcome of Brexit will have an impact across industries, but it can be hard to access the facts. Here we set out some of the issues relevant to the pharmaceutical and Life Sciences sector to help you make informed decisions about your strategic choices.
PwC comments on the latest European Commission statement on Brexit and EU Data Protection Law.
Gaenor Bagley is joined by Andrew Kail, Head of Financial Services at PwC, and Mark Hoban, Board member at TheCityUK , to discuss how the UK financial services sector is preparing for the challenges ahead and why collaboration between the industry, government and regulators is key.